ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Analyst Coverage
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Press Releases

Investors & Media

  • Home
  • Investors & Media
  • News / Events
  • Press Releases
Investors & Media

Investors & Media

  • Overview
  • News / Events
    • Press Releases
    • Media Coverage
    • Events
    • Email Alerts
  • Presentations
  • Company Information
  • Financial Information
  • Analyst Coverage
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

ContraFect Corporation Announces Issuance of Key Patent Covering Novel Lysin Technology

July 17, 2015

ContraFect Corporation Announces $20,000,000 Private Placement

June 11, 2015

ContraFect Corporation Announces First Healthy Volunteer Dosed With CF-301

May 21, 2015

ContraFect Corporation Adds Former Cubist Executive Steven C. Gilman, PhD, to Board of Directors as Executive Chairman

May 20, 2015

ContraFect Corporation Announces First Quarter 2015 Results

May 15, 2015

ContraFect Corporation Announces Commencement of Phase 1 Clinical Trial of CF-301 for Staph Bloodstream Infections, Including MRSA

April 29, 2015

ContraFect Corporation Announces Fourth Quarter and Full Year 2014 Results

April 6, 2015

ContraFect to Present at 27th Annual ROTH Conference

March 3, 2015

ContraFect to Present at 17th Annual BIO CEO & Investor Conference

February 3, 2015

ContraFect to Present Company Overview, Including Clinical Plan for CF-301, at the 7th Annual Biotech Showcase

January 7, 2015

RSS
  • « Previous
  • 1...
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next »
© 2023 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter